Table 6 Bivariate analysis for factors associated with metanephrines and normetanephrines
Risk factor | Metanephrines | Normetanephrines | ||||
|---|---|---|---|---|---|---|
Odds (95 % CI) | OR (95 % CI) | p value | Odds (95 % CI) | OR (95 % CI) | p value | |
Age in years | ||||||
≤45 | 0.08 (0.02–0.35) | 0.11 (0.04–0.31) | ||||
>45 | 0.02 (0.00–0.12) | 0.20 (0.02–2.37) | 0.154 | 0.15 (0.08–0.26) | 1.4 (0.43–4.33) | 0.604 |
Gender | ||||||
Male | 0.10 (0.02–0.41) | 0.35 (0.16–0.78) | ||||
Female | 0.02 (0.00–0.11) | 0.16 (0.01–2.00) | 0.106 | 0.10 (0.06–0.18) | 0.29 (0.11–0.79) | 0.015 |
Smoking | ||||||
No | 0.01 (0.00–0.10) | Reference | 0.11 (0.07–0.19) | Reference | ||
Stopped | 0.25 (0.05–1.18) | 18.75 (1.53–230.42) | 0.022 | 0.33 (0.09–1.23) | 2.93 (0.72–12.03) | 0.135 |
Yes | 0 | – | – | 2.00 (0.18–22.06) | 17.6 (1.50–205.82) | 0.022 |
Alcohol | ||||||
Yes | 0.11 (0.03–0.48) | 0.21 (0.09–0.50) | ||||
No | 0.02 (0.00–0.11) | 0.14 (0.01–1.69) | 0.069 | 0.13 (0.07–0.22) | 0.60 (0.21–1.71) | 0.342 |
Systolic BP | ||||||
<120 | 0 | 0.50 (0.05–5.51) | Reference | |||
120–139 | 0 | 0 | – | – | ||
140–159 | 0.05 (0.01–0.37) | Reference | 0.15 (0.06–0.38) | 0.29 (0.02–3.87) | 0.352 | |
>160 | 0.03 (0.01–0.14) | 0.67 (0.06–7.88) | 0.746 | 0.15 (0.08–0.26) | 0.30 (0.03–3.50) | 0.336 |
Diastolic BP | ||||||
<80 | 0.10 (0.01–0.78) | Reference | 0.47 (0.19–1.14) | Reference | ||
80–89 | – | – | – | 0.087 (0.02–0.37) | 0.19 (0.03–1.02) | 0.053 |
90–99 | – | – | – | 0.04 (0.01–0.30) | 0.86 (0.01–0.77) | 0.028 |
≥100 | 0.04 (0.01–0.15) | 0.36 (0.03–4.40) | 0.426 | 0.12 (0.07–0.24) | 0.27 (0.89–0.83) | 0.022 |
Pulse rate | ||||||
<60 | 0 | – | – | 0.14 (0.02–1.16) | Reference | |
61–100 | 0.04 (0.01–0.14) | – | – | 0.14 (0.09–0.24) | 1 (0.12–8.64) | 1.00 |
>100 | 0 | – | – | 0.13 (0.03–0.54) | 0.88 (0.07–11.31) | 0.919 |
Salt intake | ||||||
Yes | 0.07 (0.02–0.29) | 0.16 (0.08–0.31) | ||||
No | 0.02 (0.00–0.13) | 0.26 (0.02–3.08) | 0.249 | 0.07 (0.07–0.25) | 0.84 (0.33–2.17) | 0.724 |
FENa | ||||||
<1 | 0.04 (0.01–0.13) | 0.13 (0.08–0.22) | Reference | |||
1–2 | 0 | – | – | 0.20 (0.04–0.91) | 1.56 (0.31–7.77) | 0.586 |
>2 | 0 | – | – | 0.20 (0.02–1.71) | 1.56 (0.17–14.23) | 0.692 |
Time since diagnosis | ||||||
<1 month | 0 | Reference | 0.07 (0.01–0.50) | Reference | ||
1 to <6 months | 0.17 (0.02–1.38) | 0.86 (0.04–18.73) | 0.922 | 0.50 (0.13–2.00) | 7.50 (0.65–87.19) | 0.107 |
6 to <12 months | 0.14 (0.01–1.16) | 0.10 (0.00–1.97) | 0.060 | 0.22 (0.05–1.03) | 3.33 (0.26–42.21) | 0.353 |
>1 year | 0.02 (0.00–0.12) | 0.13 (0.07–0.22) | 1.88 (0.23–15.30) | 0.557 | ||